Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma

Oral Oncology

Volumn 49, Issue 6, 2013, Pages 620-625

  Hsu, Cheng Lung ^a   Chan, Sheng Chieh ^a   Chang, Kai Ping ^a   Lin, Tung Liang ^a   Lin, Chien Yu ^a   Hsieh, Chia Hsun ^a   Huang, Shiang Fu ^a   Tsang, Ngan Ming ^a   Lee, Li Yu ^a   Ng, Shu Hang ^a   Wang, Hung Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

DNA; EBV; Head and neck cancer; Nasopharyngeal carcinoma; PET

Indexed keywords

EPSTEIN BARR VIRUS DNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENE DOSAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DISEASE-FREE SURVIVAL; DNA PRIMERS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84877065129     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.02.006     Document Type: Article

References (31)

1. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
2. J.C. Lin, J.S. Jan, K.Y. Chen, C.Y. Hsu, W.M. Liang, and W.Y. Wang Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma Head Neck 25 2003 438 450
3. J.C. Lin, J.S. Jan, C.Y. Hsu, W.M. Liang, R.S. Jiang, and W.Y. Wang Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
4. M.K. Kam, S.F. Leung, B. Zee, R.M. Chau, J.J. Suen, and F. Mo Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879
5. P.M. Teo, W.H. Kwan, A.T. Chan, W.Y. Lee, W.W. King, and C.O. Mok How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 40 1998 897 913
6. T.W. Leung, S.Y. Tung, W.K. Sze, W.M. Sze, V.Y. Wong, and C.S. Wong Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 48 2000 1331 1338
7. J.T. Chang, L.C. See, C.T. Liao, S.H. Ng, C.H. Wang, and I.H. Chen Locally recurrent nasopharyngeal carcinoma Radiother Oncol 54 2000 135 142
8. Y.M. Lo, L.Y. Chan, K.W. Lo, S.F. Leung, J. Zhang, and A.T. Chan Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191
9. Y.M. Lo, S.F. Leung, L.Y. Chan, A.T. Chan, K.W. Lo, and P.J. Johnson Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma Cancer Res 60 2000 2351 2355
10. Y.M. Lo, L.Y. Chan, A.T. Chan, S.F. Leung, K.W. Lo, and J. Zhang Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma Cancer Res 59 1999 5452 5455
11. Y.M. Lo, A.T. Chan, L.Y. Chan, S.F. Leung, C.W. Lam, and D.P. Huang Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA Cancer Res 60 2000 6878 6881
12. J.C. Lin, W.Y. Wang, K.Y. Chen, Y.H. Wei, W.M. Liang, and J.S. Jan Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2461 2470
13. A. Mutirangura, W. Pornthanakasem, A. Theamboonlers, V. Sriuranpong, P. Lertsanguansinchi, and S. Yenrudi Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma Clin Cancer Res 4 1998 665 669
14. S.F. Leung, B. Zee, B.B. Ma, E.P. Hui, F. Mo, and M. Lai Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma J Clin Oncol 24 2006 5414 5418
15. X. An, F.H. Wang, P.R. Ding, L. Deng, W.Q. Jiang, and L. Zhang Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy Cancer 117 2011 3750 3757
16. C.L. Hsu, K.P. Chang, C.Y. Lin, H.K. Chang, C.H. Wang, and T.L. Lin Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma Head Neck 34 2012 1064 1070
17. S.H. Ng, C.T. Joseph, S.C. Chan, S.F. Ko, H.M. Wang, and C.T. Liao Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence J Nucl Med 45 2004 1669 1676
18. S.C. Chan, T.C. Yen, S.H. Ng, C.Y. Lin, H.M. Wang, and C.T. Liao Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management J Nucl Med 47 2006 1447 1454
19. S.H. Ng, S.C. Chan, T.C. Yen, J.T. Chang, C.T. Liao, and S.F. Ko Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up Eur J Nucl Med Mol Imaging 36 2009 12 22
20. F.Y. Liu, C.Y. Lin, J.T. Chang, S.H. Ng, S.C. Chin, and H.M. Wang 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma J Nucl Med 48 2007 1614 1619
21. R.F. Yen, R.L. Hong, K.Y. Tzen, M.H. Pan, and T.H. Chen Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma J Nucl Med 46 2005 770 774
22. S.H. Ng, S.C. Chan, T.C. Yen, C.T. Liao, J.T. Chang, and S.F. Ko Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT Eur Radiol 20 2010 2229 2240
23. S.H. Ng, S.C. Chan, T.C. Yen, J.T. Chang, C.T. Liao, and S.F. Ko Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT Eur Radiol 19 2009 2965 2976
24. A. Ahmad, and S. Stefani Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients J Surg Oncol 33 1986 194 197
25. W.Y. Wang, C.W. Twu, W.Y. Lin, R.S. Jiang, K.L. Liang, and K.W. Chen Plasma Epstein-Barr virus DNA screening followed by (1)(8)F-fluoro-2-deoxy-D- glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma Cancer 117 2011 4452 4459
26. W.H. Kwan, P.M. Teo, L.T. Chow, P.H. Choi, and P.J. Johnson Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment Clin Oncol (R Coll Radiol) 8 1996 55 58
27. E.P. Hui, S.F. Leung, J.S. Au, B. Zee, S. Tung, and D. Chua Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group Cancer 101 2004 300 306
28. V. Radhakrishnan, S. Thulkar, S. Karunanithi, N. Tanveer, and S. Bakhshi Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings Pediatr Radiol 40 Suppl 1 2010 S79 S82
29. M.L. Gulley Molecular diagnosis of Epstein-Barr virus-related diseases J Mol Diagn 3 2001 1 10
30. A.A. Makitie, P.P. Reis, J. Irish, T. Zhang, S.F. Chin, and X. Chen Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study Head Neck 26 2004 815 822
31. K.P. Chang, N.M. Tsang, C.T. Liao, C.L. Hsu, M.J. Chung, and C.W. Lo Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma J Nucl Med 53 2012 21 28